Share this
viral infection and immunity: the promise of remote sampling
by Neoteryx Microsampling on Mar 18, 2020 4:50:00 PM
We are living in unprecedented times. In March 2020, the World Health Organization (WHO) upgraded the COVID-19 epidemic to a pandemic and different countries implemented different ways to tackle the spread of the infectious disease known as SARS-CoV-2. Much of this involves social distancing, especially for the vulnerable in our societies.
The rapid spread of the virus put strains on healthcare systems and the WHO recommended that governments test for the virus as much as they can.
Current Ways to Test for Viral Infection
There are two primary ways to specifically test for viral infection:
- Testing for the direct presence of the virus
- Testing for antibodies raised against the virus.
Direct Viral Testing
Direct viral testing, which has been employed for diagnosis of COVID-19, involves detecting the presence of viral nucleic acids in affected tissues using rapid PCR techniques. Although rapid PCR allows for detection of specified viruses, it says nothing about if an individual has raised any antibodies to the virus.
Antibody Testing
Screening for raised antibodies, allows for vaccine manufacturers to test the efficacy of their vaccines. This involves employing the use immunoassays specific to the pathogen or pathogens of choice and involves a blood test. However, blood sampling is challenging to accomplish when social distancing measures have been employed and healthcare systems are being stretched. In short, home testing kits that enable people to mail a dried blood sample to a laboratory can potentially help to reduce such a burden.
Use of Remote Dried Blood Assays in Monitoring of Disease
The use of remote sampling of dried blood samples for diagnosis of disease is widely used in screening neonates for inborn errors of metabolism. Over the years, there have been many papers published on the use of remote dried blood collection for monitoring viral infections such as HIV and hepatitis.
In 2019, a paper was published in the Journal of Clinical and Translational Science, where the use of remote Volumetric Absorptive Microsampling was evaluated to successfully measure immunity to 33 stains of influenza virus. The test employed by the research lab was a multidimensional multiplex immunoassay to measure IgG antibodies. Twenty-one healthy volunteers were recruited to evaluate the feasibility of combining the benefits of at-home finger-stick blood sampling, with the mPlex-Flu assay.
In each case, phlebotomists were used to collect both venous blood via a traditional venipuncture blood draw, and capillary blood samples using Mitra devices and a lancet to prick the fingertip. The study volunteers were also asked to self-collect additional blood samples at home using Mitra® devices based on VAMS® technology. This enabled them to mail the sampled devices back to the lab.
The results were very impressive, including the following highlights:
- Very good concordance (R2 0.9470) was observed when comparing the venous serum samples vs. extracts from the dried Mitra samples collected by the phlebotomists;
- Equally excellent concordance (R2 0.9496) was observed between Mitra samples collected by the phlebotomists and the samples self-collected by volunteers at home;
- The samples looked very stable and, even more encouraging, this study was conducted in the New York area during an August heatwave where the samples mailed back to the lab would have been exposed to high temperatures.
Can microsampling be used for COVID-19?
We contacted the lead author on the study (Dr. Jiong Wang) to see if their research group was developing a similar assay for COVID-19. She reported, "We are going to be using the same methods to estimate the antibodies against COVID-19 viral proteins, such as S, N, M, E and multiple strains. That will be helpful for vaccine development and understanding the mechanism of COVID-19 severe illness. We intend to use the Mitra® Microsample Collection Kits for large scale sampling."
More Microsampling Information
If you are curious to explore remote microsampling and how volumetric dried blood assays can help track viral infection and immunity, please contact us to speak with one of our expert Microsampling Specialists.
Share this
- Microsampling (206)
- Research, Remote Research (119)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (73)
- Therapeutic Drug Monitoring, TDM (50)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Decentralized Clinical Trial (DCT) (22)
- Blood Microsampling, Serology (21)
- Omics, Multi-Omics (19)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Skin Microsampling, Microbiopsy (11)
- Pharmaceuticals, Drug Development (9)
- Industry News, Microsampling News (5)
- Harpera Device (4)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- October 2024 (3)
- September 2024 (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think